Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats

Diastolic dysfunction is a prognosticator for future cardiovascular events that demonstrates a strong correlation with obesity. Pharmacological inhibition of dipeptidylpeptidase-4 (DPP-4) to increase the bioavailability of glucagon-like peptide-1 is an emerging therapy for control of glycemia in typ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Aroor, Annayya R., Sowers, James R., Bender, Shawn B., Nistala, Ravi, Garro, Mona, Mugerfeld, Irina, Hayden, Melvin R., Johnson, Megan S., Salam, Muhammad, Whaley-Connell, Adam, DeMarco, Vincent G.
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2013
Sujets:
Renal-Cardiac-Vascular
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3689282/
https://ncbi.nlm.nih.gov/pubmed/23653460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2013-1096
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires